J&J to start human trials for COVID-19 vaccine this week

Johnson & Johnson will begin human trials for its experimental COVID-19 vaccine July 22, according to The Wall Street Journal.

The initial trial, which will involve 1,000 participants, will begin in Belgium, followed shortly by testing in the U.S. Researchers will evaluate the vaccine candidate's safety and ability to produce an immune response.